Tandem Diabetes Care, Inc. (TNDM) fundamentals score
References within this Annual Report to “Tandem,” “we,” “its,” “it,” “management,” or the “Company” refer to Tandem Diabetes Care, Inc., together with its wholly-owned subsidiaries.
Surgical & Medical Instruments & Apparatus · Healthcare · Listed on NASDAQ
Overall: 5.0 out of 10, Mixed fundamentals
- Growth: 4.9/10
- Profitability: 4.7/10
- Financial health: 3.3/10
- Earnings quality: 8.3/10
- Valuation: 4.3/10
Scores are calculated from Tandem Diabetes Care, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10